BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19/09/2018

Postapproval Changes to Drug Substances; Draft Guidance for Industry; Availability; Correction

The Food and Drug Administration is correcting a notice entitled "Postapproval Changes to Drug Substances; Draft Guidance for Industry; Availability" that appeared in the Federal Register of September 11, 2018. The document announced a draft guidance that provides recommendations to holders of approved new drug applications, abbreviated new drug applications, new animal drug applications, abbreviated new animal drug applications, and holders of drug master files and veterinary master files who may want to make a change to the drug substance manufacturing process during the drug product application postapproval period. The document was published with the incorrect docket number. This document corrects that error.

Source: Federal Register — Food and Drug AdministrationOpen original release →